Addex Therapeutics Ltd. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.03M1.49M1.80M0.46M
Cost of Revenue 0.33M0.37M0.02M
Gross Profit -0.03M1.16M1.43M0.44M
Operating items
Depreciation & Amortization - Total -0.03M-0.31M0.01M-0.21M
Research & Development 8.64M1.32M0.97M
Selling, General & Administrative 3.92M2.98M2.63M
Other Operating Expenses 0.31M-0.01M0.21M
Operating Expenses -0.03M12.56M4.30M3.60M
Operating Income -11.05M-2.50M-3.13M
EBIT -11.05M-2.50M-3.13M
Non-operating items
Interest & Investment Income 0.03M0.07M0.03M
Other Non Operating Income 763.86M-0.28M-0.35M0.02M
Non Operating Income -0.28M-0.29M0.03M
Net income details
EBT -11.33M-2.78M-5.58M
Profit After Tax -21.81M-11.75M8.02M
Equity Income -2.50M
Income from Continuing Operations -11.33M-2.78M-5.58M
Consolidated Net Income -10.48M-8.97M13.60M
Income towards Parent Company -10.48M-8.97M13.60M
Net Income towards Common Stockholders -21.81M-11.75M8.02M
Additional items
EPS (Basic) -0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 26.50M26.50M26.69M26.67M37.88M74.91M98.32M
EBITDA -11.36M14.34M-3.34M